March 2024 FDA Recall Betimol by Thea Pharma, Inc.
D-0374-2024 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Thea Pharma, Inc. on March 5, 2024 for the product Betimol. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0374-2024

Reason for Recall
Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
Initiated
03-05-2024
Reported
03-20-2024
Quantity
5,476 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed nationwide within the United States
Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15

Batch or Lot Expiration Information

Lot# : 435019, Exp. Date 11/2024